单期增强CT能否鉴别肾上腺腺瘤与肾上腺转移瘤
本研究回顾性纳入61例肺癌登记患者的单期增强CT(40例转移瘤、36例腺瘤),由两位放射科医师盲法评估边缘光滑、环形强化、中央静脉征及均匀性(5分Likert量表),第三位测量大小、衰减值并做纹理分析。转移瘤较腺瘤大(24±11 mm vs 19±5 mm,p=0.012)且熵更高(AUC 0.65),但两组衰减值无显著差异;Likert 4或5分诊断转移瘤特异度97.2%但敏感度仅32.5%(医师1)和22.5%(医师2)。结论:单期增强CT不能可靠鉴别肾上腺转移瘤与腺瘤。
要点
- 转移瘤与腺瘤的衰减值无显著差异(58.2±21.0 HU vs 55.5±21.5 HU,p=0.582)。
- 转移瘤更大(24±11 mm vs 19±5 mm,p=0.012)且熵更高(AUC 0.65,95%CI 0.52-0.77),但敏感度低。
核心结论
- 单期增强CT不能可靠鉴别肾上腺转移瘤与腺瘤;肿瘤增大和异质性为特异性征象但敏感度低。
研究设计与样本
- 回顾性研究纳入单中心肺癌登记中61例连续患者(40例转移瘤、36例腺瘤),均行基线单期增强CT;两位放射科医师盲法独立评估四项征象,第三位测量大小、衰减值并行定量纹理分析,采用卡方检验、logistic回归和ROC分析。
关键影像表现/征象
- 转移瘤平均大小24±11 mm(范围11-66 mm)大于腺瘤19±5 mm(范围11-34 mm),p=0.012,两组有重叠。
- 转移瘤衰减值58.2±21.0 HU(范围21.0-108.0 HU)与腺瘤55.5±21.5 HU(范围14.0-105.0 HU)无显著差异,p=0.582。
- 转移瘤熵值高于腺瘤(p=0.013),偏度与峰度无显著差异(p=0.612和0.978)。
- 两位医师均认为转移瘤异质性更高(p=0.001和0.011),医师间一致性满意(κ=0.51)。
- 肿瘤边缘、环形强化及中央静脉征在两组间无显著差异(p>0.05)。
诊断标准与关键数值
- 熵诊断转移瘤的AUC为0.65(95%CI 0.52-0.77)。
- Likert评分4或5分(大部分或完全异质性)诊断转移瘤:医师1敏感度32.5%、特异度97.2%;医师2敏感度22.5%、特异度97.2%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to evaluate whether adrenal metastases can be reliably differentiated from adenomas at single-phase contrast-enhanced CT.
MATERIALS AND METHODS: Sixty-one consecutive patients from a single-institution lung cancer registry (40 metastases and 36 adenomas) who underwent single-phase contrast-enhanced CT at baseline diagnosis were retrospectively studied by two radiologists (blinded to the diagnoses) who independently evaluated four features previously described in adenomas: smooth margin, rim enhancement, central vein sign (preserved adrenal vein), and homogeneity (using a 5-point Likert scale). A third radiologist measured size and attenuation and performed quantitative texture analysis. Comparisons were performed using chi-square, logistic regression, and ROC analysis.
RESULTS: Metastases were larger than adenomas (mean [± SD] 24 ± 11 mm [range, 11-66 mm] vs 19 ± 5 mm [range, 11-34 mm]; p = 0.012), with overlap between groups. Attenuation of metastases and adenomas did not differ significantly (58.2 ± 21.0 HU [range, 21.0-108.0] vs 55.5 ± 21.5 HU [range, 14.0-105.0]; p = 0.582). Skewness and kurtosis did not differ between groups (p = 0.612 and 0.978, respectively), whereas entropy was higher in metastases (p = 0.013). The AUC for entropy to diagnose metastases was 0.65 (95% CI, 0.52-0.77). Tumor margin, rim enhancement, and the central vein sign did not differ between groups (p > 0.05). Metastases were considered more heterogeneous by both radiologists (p = 0.001 and 0.011, respectively), and agreement was satisfactory (κ = 0.51). Likert scores of 4 or 5 (mostly or completely heterogeneous) yielded sensitivity and specificity for diagnosis of metastases of 32.5% and 97.2%, respectively, for radiologist 1 and 22.5% and 97.2%, respectively, for radiologist 2.
CONCLUSION: Adrenal metastases cannot be reliably differentiated from adenomas at single-phase contrast-enhanced CT. Increased tumor size and heterogeneity were specific findings but showed unacceptably low sensitivity.
引用
- Tu W, Verma R, Krishna S, et al. Can Adrenal Adenomas Be Differentiated From Adrenal Metastases at Single-Phase Contrast-Enhanced CT? AJR Am J Roentgenol. 2018. PMID: 30207794. doi:10.2214/AJR.17.19276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。